Notes
cardiovascular disease events
Reference
NICE. NICE issues draft guidance on evolocumab for lipid disorder. Media Release : 18 Nov 2015. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE not recommending evolocumab for high cholesterol. PharmacoEcon Outcomes News 742, 36 (2015). https://doi.org/10.1007/s40274-015-2664-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2664-y